| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 4.908 | 14.477 | 9.920 | 15.666 | 7.995 | 0 | 0 |
| Total Income - EUR | - | - | 0 | 14.019 | 26.646 | 25.375 | 49.279 | 14.815 | 3.265 | 0 |
| Total Expenses - EUR | - | - | 479 | 20.981 | 37.197 | 33.208 | 23.221 | 14.842 | 8.294 | 1.712 |
| Gross Profit/Loss - EUR | - | - | -479 | -6.963 | -10.551 | -7.833 | 26.058 | -27 | -5.029 | -1.712 |
| Net Profit/Loss - EUR | - | - | -479 | -7.017 | -10.697 | -7.925 | 25.842 | -544 | -5.029 | -1.712 |
| Employees | - | - | 0 | 2 | 2 | 2 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Primared Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 29 | 41.116 | 35.792 | 30.536 | 24.479 | 17.655 | 10.009 | 8.341 |
| Current Assets | - | - | 39 | 11.645 | 8.840 | 12.040 | 8.854 | 2.099 | 4.690 | 201 |
| Inventories | - | - | 0 | 8.082 | 7.845 | 11.655 | 7.569 | 937 | 148 | 148 |
| Receivables | - | - | 0 | 287 | 63 | 55 | 0 | 52 | 3.893 | 51 |
| Cash | - | - | 39 | 3.275 | 932 | 330 | 1.285 | 1.110 | 649 | 2 |
| Shareholders Funds | - | - | -436 | -7.445 | -17.997 | -25.581 | 828 | 287 | -4.742 | -6.428 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 503 | 20.444 | 28.271 | 39.068 | 32.814 | 19.550 | 19.458 | 14.987 |
| Income in Advance | - | - | 0 | 40.068 | 34.630 | 29.399 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1032 - 1032" | |||||||||
| CAEN Financial Year |
1032
|
|||||||||
Comments - Primared Bio S.r.l.